Article metrics
Abstract
Free Communications
RANDOMIZED PHASE III TRIAL OF CISPLATIN VS CISPLATIN PLUS TOPOTECAN VS THE COMBINATION OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN (MVAC) IN STAGE IVB, RECURRENT OR PERSISTENT CARCINOMA OF THE UTERINE CERVIX: A GYNECOLOGIC ONCOLOGY GROUP STUDY
